Xi Hui Felicia Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xi Hui Felicia Chan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Baiyi Chi
Skin Health and Cosmetic Development & Evaluation Laboratory, China Pharmaceutical University, Nanjing, China
1 shared publication- Gangshi Wang
Chinese PLA General Hospital
1 shared publication Huijuan Li
Skin Health and Cosmetic Development & Evaluation Laboratory, China Pharmaceutical University, Nanjing, China
1 shared publication- Jianxin Wu
Skin Health and Cosmetic Development & Evaluation Laboratory, China Pharmaceutical University, Nanjing 211198, China
1 shared publication - Pan Wang
Skin Health and Cosmetic Development & Evaluation Laboratory, China Pharmaceutical University, Nanjing, China
1 shared publication - Qing Huang
Center of Skin Health and Cosmetic Development & Evaluation, China Pharmaceutical University, Nanjing 210009, China
1 shared publication
Latest Publications
- Open Access
- 31 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Microecology in vitro model replicates the human skin microbiome interactions
Skin microecology involves a dynamic equilibrium among the host, microbiome, and internal/external environments. This equilibrium, shaped by multifactorial interactions, reflects individual specificity and diversity. Creating a replicable in vitro skin microecological model is highly challenging. Here, we introduce a mimicked stratum corneum microecology model (SCmic). It uses light cured crosslinked hydrogels as a scaffold and moisture source, and nonviable epidermal cells as the main nutrient. This setup establishes a suitable, stable, and reproducible microecology for microbiome colonization. Notably, it replicates the normal/oily skin microbiota with no significant differences from the original native microbiota at the genus level. Simultaneously, we have developed a standardized human skin microbiota model (Hcm), featuring seven dominant strains that form a representative microbial community. The models provide highly convenient approaches for exploring the intricate mutual interactions among skin microecology, influence of microbiota on skin health, and metabolism of chemical substances by microbiota.
- 31 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessMicroecology in vitro model replicates the human skin microbiome interactions
Skin microecology involves a dynamic equilibrium among the host, microbiome, and internal/external environments. This equilibrium, shaped by multifactorial interactions, reflects individual specificity and diversity. Creating a replicable in vitro skin microecological model is highly challenging. Here, we introduce a mimicked stratum corneum microecology model (SCmic). It uses light cured crosslinked hydrogels as a scaffold and moisture source, and nonviable epidermal cells as the main nutrient. This setup establishes a suitable, stable, and reproducible microecology for microbiome colonization. Notably, it replicates the normal/oily skin microbiota with no significant differences from the original native microbiota at the genus level. Simultaneously, we have developed a standardized human skin microbiota model (Hcm), featuring seven dominant strains that form a representative microbial community. The models provide highly convenient approaches for exploring the intricate mutual interactions among skin microecology, influence of microbiota on skin health, and metabolism of chemical substances by microbiota.
- 1 November 2024
- Published by Wiley in Helicobacter
- Vol. 29 (6) , e70004
Combatting Helicobacter pylori: A Focus on Nanomaterials
Developing effective non‐antibiotic antimicrobial strategies is essential for combating global antibiotic resistance, including resistance stemming from Helicobacter pylori (H. pylori) treatment. Nanomaterials offer a promising and innovative approach for non‐antibiotic anti‐H. pylori treatment strategies. This review highlights the progress made in the use of metallic and nonmetallic nanoparticles, as well as nanozymes, to directly inhibit H. pylori growth. Moreover, we summarize advances made in the direct targeting of H. pylori by nanomaterials and the stimuli‐responsive release of nanoparticles in the stomach. Additionally, we explore the recent advancements in multifunctional nanoplatforms that integrate physical methods, such as light, heat, ultrasound, and magnetism, with nanomaterials to synergistically treat H. pylori infections. Finally, we briefly address the existing challenges and future directions in this field. In summary, we highlight that with ongoing research, nanomaterials may serve as a promising treatment strategy for H. pylori eradication.
- 1 November 2024
- Published by Wiley in Helicobacter
- Vol. 29 (6) , e70004
Combatting Helicobacter pylori: A Focus on Nanomaterials
Developing effective non‐antibiotic antimicrobial strategies is essential for combating global antibiotic resistance, including resistance stemming from Helicobacter pylori (H. pylori) treatment. Nanomaterials offer a promising and innovative approach for non‐antibiotic anti‐H. pylori treatment strategies. This review highlights the progress made in the use of metallic and nonmetallic nanoparticles, as well as nanozymes, to directly inhibit H. pylori growth. Moreover, we summarize advances made in the direct targeting of H. pylori by nanomaterials and the stimuli‐responsive release of nanoparticles in the stomach. Additionally, we explore the recent advancements in multifunctional nanoplatforms that integrate physical methods, such as light, heat, ultrasound, and magnetism, with nanomaterials to synergistically treat H. pylori infections. Finally, we briefly address the existing challenges and future directions in this field. In summary, we highlight that with ongoing research, nanomaterials may serve as a promising treatment strategy for H. pylori eradication.